Driving Residual Neuromuscular Blockade to Zero: Precision Matters

Ken B. Johnson
DOI: https://doi.org/10.1213/ane.0000000000007064
IF: 6.627
2024-08-18
Anesthesia & Analgesia
Abstract:Professional practice guidelines and consensus statements developed during the last 10 years recommend the use of quantitative neuromuscular monitors (NMMs) when neuromuscular blocking (NMB) drugs are used. 1–4 In the era of sugammadex, anesthesia providers may wonder why to use a more complex monitor when sugammadex is such an effective reversal agent unless an agent like atracurium is used? Advanced monitoring techniques are an interesting academic exercise but can be a nuisance in a busy clinical practical. This level of skepticism may present a significant hurdle to their widespread adoption.
anesthesiology
What problem does this paper attempt to address?